Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Allolio

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
Nature Communications|December 6, 2014
PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunitDavide Calebiro, Annette Hannawacker, Sandra Lyga, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2013
[¹²³I]Iodometomidate imaging in adrenocortical carcinomaMichael C Kreissl, Andreas Schirbel, Martin Fassnacht, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcomePatrick Adam, Stefanie Hahner, Martina Hartmann, et al.
Frontiers in Endocrinology|June 2, 2012
Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma CellsMatthias Kroiss, Miriam Reuss, Dorothee Kühner, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
Plos One|August 22, 2014
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinomaCristina L Ronchi, Silviu Sbiera, Marco Volante, et al.
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
European Urology|June 29, 2010
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patientsDavid Brix, Bruno Allolio, Wiebke Fenske, et al.
The Journal of Endocrinology|August 11, 2006
Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone productionAnthony P Coll, Martin Fassnacht, Steffen Klammer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter studyIlse G Hermsen, Martin Fassnacht, Massimo Terzolo, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
Nature Communications|December 6, 2014
PKA catalytic subunit mutations in adrenocortical Cushing's adenoma impair association with the regulatory subunitDavide Calebiro, Annette Hannawacker, Sandra Lyga, et al.
The Journal of Clinical Endocrinology and Metabolism|April 24, 2013
[¹²³I]Iodometomidate imaging in adrenocortical carcinomaMichael C Kreissl, Andreas Schirbel, Martin Fassnacht, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 10, 2010
Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcomePatrick Adam, Stefanie Hahner, Martina Hartmann, et al.
Frontiers in Endocrinology|June 2, 2012
Sunitinib Inhibits Cell Proliferation and Alters Steroidogenesis by Down-Regulation of HSD3B2 in Adrenocortical Carcinoma CellsMatthias Kroiss, Miriam Reuss, Dorothee Kühner, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2012
Sunitinib in refractory adrenocortical carcinoma: a phase II, single-arm, open-label trialMatthias Kroiss, Marcus Quinkler, Sarah Johanssen, et al.
Plos One|August 22, 2014
CYP2W1 is highly expressed in adrenal glands and is positively associated with the response to mitotane in adrenocortical carcinomaCristina L Ronchi, Silviu Sbiera, Marco Volante, et al.
European Journal of Endocrinology|August 28, 2015
Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's RegistryGregor Hanslik, Henri Wallaschofski, Anna Dietz, et al.
European Urology|June 29, 2010
Laparoscopic versus open adrenalectomy for adrenocortical carcinoma: surgical and oncologic outcome in 152 patientsDavid Brix, Bruno Allolio, Wiebke Fenske, et al.
The Journal of Endocrinology|August 11, 2006
Peripheral administration of the N-terminal pro-opiomelanocortin fragment 1-28 to Pomc-/- mice reduces food intake and weight but does not affect adrenal growth or corticosterone productionAnthony P Coll, Martin Fassnacht, Steffen Klammer, et al.
The Journal of Clinical Endocrinology and Metabolism|April 8, 2011
Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter studyIlse G Hermsen, Martin Fassnacht, Massimo Terzolo, et al.
Pageof 15